Key facts
- Notable investors include DFJ Fund.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Jingda Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Jingda Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Jingda Biotechnology
Operator of a biopharmaceutical and biotechnology platform based in Shanghai, China. The company specailises in the development of gene and cell drugs, specifically NK and CAR-NK drugs.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2020
- Ownership
- Privately Held (backing)
Jingda Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Jingda Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Jingda Biotechnology in its N-PORT filings yet. We sweep new filings monthly.